| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Chief Executive Officer
1 company
Cooper Laurence James Neil is a President And CEO at Alaunos Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 2 sells.
Estimated insider holdings value: $4.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2021 | TCRT Alaunos Therapeutics, Inc. | President And CEO | Sell | 105,693 | $2.71 | $286,428.03 | -5.5% | |
| Dec 30, 2019 | TCRT Alaunos Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 110,694 | $4.88 | $540,186.72 | -6.0% | |
| Nov 8, 2017 | TCRT Alaunos Therapeutics, Inc. | Chief Executive Officer | Buy | 6,440 | $4.68 | $30,139.20 | +0.6% |